Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
0.5110
-0.0093 (-1.79%)
At close: Aug 28, 2026, 4:00 PM EDT
0.5116
+0.0006 (0.12%)
After-hours: Aug 28, 2026, 7:40 PM EDT

Adagio Medical Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
--0.60.30.190.27
Revenue Growth
--100.67%58.73%-30.00%-
Cost of Revenue
0.090.683.321.310.881.16
Gross Profit
-0.09-0.68-2.72-1.01-0.69-0.89
Selling, General & Admin
9.5310.5720.0211.545.374.4
Research & Development
10.210.6412.2215.417.8615.36
Operating Expenses
19.7321.2132.2426.9423.2319.76
Operating Income
-19.82-21.89-34.96-27.94-23.91-20.65
Interest Expense
-3.11-2.91-2.92-1.66-0.14-
Interest & Investment Income
0.390.480.4200.040
Other Non Operating Income (Expenses)
-4.6-0.7711.62-6.990.34-0.04
EBT Excluding Unusual Items
-27.14-25.08-25.84-36.59-23.67-20.68
Impairment of Goodwill
---30.32---
Asset Writedown
---18.88---
Other Unusual Items
-----0.74
Pretax Income
-27.14-25.08-75.04-36.59-23.67-19.94
Net Income
-27.14-25.08-75.04-36.59-23.67-19.94
Net Income to Common
-27.14-25.08-75.04-36.59-23.67-19.94
Net Income Growth
------
Shares Outstanding (Basic)
20177111
Shares Outstanding (Diluted)
20177111
Shares Change
42.93%147.85%780.27%1.10%2.36%-
EPS (Basic)
-1.36-1.51-11.22-48.16-31.50-27.15
EPS (Diluted)
-1.36-1.51-11.22-48.16-31.50-27.15
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-16.57-19.39-31.11-25.99-22.9-20.57
Free Cash Flow Per Share
-0.83-1.17-4.65-34.20-30.48-28.01
Operating Margin
---5806.98%-9314.00%-12652.38%-7646.30%
Profit Margin
---12465.28%-12196.67%-12525.40%-7384.44%
Free Cash Flow Margin
---5167.28%-8661.67%-12118.52%-7616.67%
EBITDA
-18.98-20.92-33.57-27.41-23.42-20.31
D&A For EBITDA
0.840.971.390.530.50.34
EBIT
-19.82-21.89-34.96-27.94-23.91-20.65
SEC Filings: 10-K · 10-Q